FACTANKER · measured, cited, anchored official records connected
FACTANKERSearch ↗

SEC EDGAR CompanyFacts fact · reporting period

enGene Therapeutics Inc.: cashflow_investing

One fact, its scope and the complete path back to the official record.

Period: 2025-11-01 – 2026-07-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/e8fd48f3-06c0-4f5c-9a98-b46f569777c4

Reported value

$-72.538M{"amount": -72538000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Entity
enGene Therapeutics Inc.
Metric
cashflow_investing
Period
2025-11-01 – 2026-07-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001193125-26-384383 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-09-10T09:48:00.756635+02:00
Raw response SHA-256f189b01035523ec467ca427a3b7716d9…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001980845/cashflow-investing/2026-07-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.

All facts for this organization →Query facts through API / MCP →Versioning policy →
From the Record
18% of job ads mention AI. Only 2% are AI jobs — and two thirds of the mentions come from 22 companies that say it in every ad.
Read the findingSearch 53 million companies